These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2986033)

  • 1. Treatment of rats with the TRH analog MK-771. Down-regulation of TRH receptors and behavioral tolerance.
    Simasko SM; Horita A
    Neuropharmacology; 1985 Feb; 24(2):157-65. PubMed ID: 2986033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central muscarinic cholinergic antagonists block wet-dog shakes produced by the TRH analog MK-771 in the rat.
    Sills MA; Mellow AM; Sunderland T; Jacobowitz DM
    Brain Res; 1988 Jun; 453(1-2):385-8. PubMed ID: 3135919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic administration of desipramine or nialamide decreases wet-dog shakes in rats produced by the TRH-analog MK-771.
    Sills MA; Jacobowitz DM
    Brain Res; 1987 Jan; 401(1):195-9. PubMed ID: 3101979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative pharmacology of the behavioral syndromes induced by TRH and by 5-HT in the rat.
    Pranzatelli MR
    Gen Pharmacol; 1988; 19(2):205-11. PubMed ID: 2895033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
    Helke CJ; Phillips ET
    J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thyrotropin-releasing hormone analogues on body shaking and prolactin levels in estrogen-primed and nonprimed rats.
    Yamada K; Kumagai M; Nagashima M; Matsuo N; Furukawa T
    Arch Int Pharmacodyn Ther; 1989; 297():235-46. PubMed ID: 2499289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative behavioural and biochemical effects of repeated intrathecal administration of thyrotrophin-releasing hormone (TRH) or two analogues of TRH in adult rats.
    Fone KC; Johnson JV; Marsden CA; Bennett GW
    Neuropharmacology; 1989 Aug; 28(8):867-75. PubMed ID: 2476681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.
    Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A
    Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat.
    Yamada K; Demarest KT; Moore KE
    Neuropharmacology; 1984 Jul; 23(7A):735-9. PubMed ID: 6433220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues.
    Ogawa N; Mizuno S; Mori A; Nukina I; Ota Z; Yamamoto M
    Peptides; 1984; 5(4):743-6. PubMed ID: 6436797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thyrotropin-releasing hormone (TRH) and MK-771 on schedule-controlled behavior of squirrel monkeys, rabbits and pigeons.
    Barrett JE
    Peptides; 1983; 4(2):177-81. PubMed ID: 6413956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency of the N3im-methyl analog of TRH in the induction of shaking movements in the rat.
    Wei E; Loh H; Way EL
    Eur J Pharmacol; 1976 Mar; 36(1):227-9. PubMed ID: 816658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of TRH and serotonin receptors: chronic TRH and analog administration in the rat.
    Pranzatelli MR; Dailey A; Markush S
    J Recept Res; 1988; 8(5):667-81. PubMed ID: 2839679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic thyrotropin releasing hormone (TRH) administration on TRH receptors and muscarinic cholinergic receptors in CNS.
    Ogawa N; Mizuno S; Nukina I; Tsukamoto S; Mori A
    Brain Res; 1983 Mar; 263(2):348-50. PubMed ID: 6301651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of TRH, DN-1417 and MK-771 to TRH receptors in the rat brain. Relationship to their central actions.
    Funatsu K; Teshima S; Inanaga K
    Kurume Med J; 1983; 30 Suppl():S45-50. PubMed ID: 6090771
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethanol-induced locomotor stimulation in rats after thyrotropin-releasing hormone.
    Breese GR; Coyle S; Towle AC; Mueller RA; McCown TJ; Frye GD
    J Pharmacol Exp Ther; 1984 Jun; 229(3):731-7. PubMed ID: 6427448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine interactions with central thyroid-releasing hormone binding sites: characterization and physiological significance.
    Rinehart RK; Barbaz B; Iyengar S; Ambrose F; Steel DJ; Neale RF; Petrack B; Bittiger H; Wood PL; Williams M
    J Pharmacol Exp Ther; 1986 Jul; 238(1):178-85. PubMed ID: 3014114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intrathecal proctolin administration on the behaviour evoked by the thyrotrophin-releasing hormone (TRH) analogue (RX 77368) and the indoleamine, TRH, substance P and calcitonin gene-related peptide levels and choline acetyltransferase activity in the rat spinal cord.
    Fone KC; Johnson JV; Bennett GW; Marsden CA
    Brain Res; 1988 Sep; 460(1):22-8. PubMed ID: 2464406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of wet-dog shaking in rats by analogues and metabolites of thyrotrophin-releasing hormone (TRH).
    Webster VA; Griffiths EC; Slater P
    Regul Pept; 1982 Dec; 5(1):43-51. PubMed ID: 6820171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
    Fone KC; Johnson JV; Bennett GW; Marsden CA
    Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.